Product Description: Salvianolic acid C is a noncompetitive Cytochrome P4502C8 (CYP2C8) inhibitor and a moderate mixed inhibitor of Cytochrome P45022J2 (CYP2J2), with Kis of 4.82 μM and 5.75 μM for CYP2C8 and CYP2J2, respectively.
Applications: Cancer-programmed cell death
Formula: C26H20O10
References: [1]Xu MJ, et al. Inhibitory Effects of Danshen components on CYP2C8 and CYP2J2. Chem Biol Interact. 2018 Jun 1;289:15-22./[2]Song J, et al. Activation of Nrf2 signaling by salvianolic acid C attenuates NF‑κB mediated inflammatory response both in vivo and in vitro. Int Immunopharmacol. 2018 Oct;63:299-310.
CAS Number: 115841-09-3
Molecular Weight: 492.43
Compound Purity: 99.94
Research Area: Cancer
Solubility: DMSO : 50 mg/mL (ultrasonic)
Target: Cytochrome P450